Published online Feb 7, 2024. doi: 10.3748/wjg.v30.i5.440
Peer-review started: October 3, 2023
First decision: December 4, 2023
Revised: December 15, 2023
Accepted: January 11, 2024
Article in press: January 11, 2024
Published online: February 7, 2024
Processing time: 119 Days and 14.5 Hours
During the treatment of type 1 gastric variceal hemorrhage (GOV1), endoscopic band ligation (EBL), endoscopic tissue adhesive injection (TAI) and endoscopic injection sclerotherapy can cause serious complications. Therefore, individualized treatment is urgently needed.
The optimal individualized therapy for patients with mild or moderate GOV1 has yet to be identified. It is important to choose the appropriate treatment modality according to the type, morphology and severity of varicose veins to further improve the treatment efficacy and minimize the incidence of associated complications. Thus, this new treatment will greatly reduce patient suffering.
We focused on comparing the differences between the EBL and TAI treatments. This study provides new ideas for the treatment of mild and moderate GOV1.
This retrospective study compared the efficacy, safety and costs of EBL and TAI. A detailed comparison of the varicose-relief rate, operative time, operation success rate, mortality rate within 6 wk, rebleeding rate, 6-wk operation-related ulcer healing rate, complication rate and average operation cost was performed.
EBL has a higher one-time varix eradication rate, a higher 6-wk operation-related ulcer healing rate, a lower delayed rebleeding rate and a lower cost than TAI for mild to moderate GOV1.
This study provides a new method for the treatment of mild to moderate GOV1:EBL.
EBL has a higher one-time varix eradication rate, higher 6-wk operation-related ulcer healing rate, lower delayed rebleeding rate and lower cost than TAI for mild to moderate GOV1.